+Search query
-Structure paper
Title | Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode |
---|---|
Journal, issue, pages | Bioorg. Med. Chem. Lett., Vol. 20, Page 1543-1547, Year 2010 |
Publish date | Jan 10, 2010 (structure data deposition date) |
Authors | Meyers, M.J. / Pelc, M. / Kamtekar, S. / Day, J. / Poda, G.I. / Hall, M.K. / Michener, M.L. / Reitz, B.A. / Mathis, K.J. / Pierce, B.S. ...Meyers, M.J. / Pelc, M. / Kamtekar, S. / Day, J. / Poda, G.I. / Hall, M.K. / Michener, M.L. / Reitz, B.A. / Mathis, K.J. / Pierce, B.S. / Parikh, M.D. / Mischke, D.A. / Long, S.A. / Parlow, J.J. / Anderson, D.R. / Thorarensen, A. |
External links | Bioorg. Med. Chem. Lett. / PubMed:20137931 |
Methods | X-ray diffraction |
Resolution | 2.5 - 3.4 Å |
Structure data | PDB-3lcd: PDB-3lco: |
Chemicals | ChemComp-SO4: ChemComp-BDY: ChemComp-HOH: ChemComp-LC0: |
Source |
|
Keywords | TRANSFERASE / Kinase CFMS CSF-1R CSF tyrosine-kinase colony stimulating factor 1 receptor / ATP-binding / Disulfide bond / Glycoprotein / Immunoglobulin domain / Kinase / Membrane / Nucleotide-binding / Phosphoprotein / Proto-oncogene / Receptor / Transmembrane / Tyrosine-protein kinase |